Assessment of a rapid referral pathway for suspected colorectal cancer in Madrid

Family Practice

Volumn 29, Issue 2, 2012, Pages 182-188

  Valentín lópez, Beatriz ^a   Ferrándiz santos, Juan ^b   Blasco amaro, Juan Antonio ^a   Morillas sáinz, Juan Diego ^c   Ruiz lópez, Pedro ^d  

^a Health Technology Assessment Unit UETS   (Spain)

^b Department of Quality Assurance   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Colorectal cancer; Early detection of cancer; Rapid referral; Waiting times

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; PATIENT REFERRAL; PUBLIC HEALTH;

EID: 84859246149     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmr080     Document Type: Article

References (27)

1. Ferlay J, Autier P, Boniol M et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581-92.
2. Faivre J, Lepage C. Changes in the management of cancer: the example of colorectal cancer. In: Coleman MP, Alexe DM, Albreht T. Responding to the Challenge of Cancer in Europe, Ljubljana, Slovenia: Institute of Public Health of the Republic of Slovenia, 2008, pp.135-50.
3. Cabanes A, Pérez-Gómez B, Aragonés N, Pollán M, López-Abente G. La situación del cáncer en España. 1975-2006. Madrid, Spain. Área de Epidemiología Ambiental y Cáncer. Centro Nacional de Epidemiología. Instituto de Salud Carlos III. http://www.isciii.es/htdocs/pdf/epicancerjunio2009.pdf (accessed on 28 September 2011).
4. Instituto de Salud Carlos III (ISCIII). Mortalidad por cáncer y otras causas en España, Año 2007. Madrid, Spain.Área de Epidemiología Ambiental y Cáncer. Centro Nacional de Epidemiología. ISCIII. http://www.isciii.es/htdocs/pdf/mort2007.pdf (accessed on 28 September 2011).
5. Department of Health. Referral Guidelines for Bowel Cancer. London, UK: Department of Health, 2002.
6. Gonzalez-Hermoso F, Perez-Palma J, Marchena-Gomez J, Lorenzo-Rocha N, Medina-Arana V. Can early diagnosis of symptomatic colorectal cancer improve the prognosis? World J Surg 2004; 28: 716-20.
7. Ciccolallo I, Capocaccia R, Coleman MP et al. Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut 2005; 54: 268-73.
8. Potter S, Govindarajulu S, Shere M et al. Referral patterns, cancer diagnoses, and waiting times after introduction of two week wait rule for breast cancer: prospective cohort study. BMJ 2007; 335: 288. doi:10.1136/bmj.39258.688553.55. (published Online first: 13 July 2007).
9. Colina F, Ferrándiz J, Manzano ML et al. Protocolo de Diagnóstico y Derivación del Cáncer Colorrectal. Madrid, Spain: Atención Especializada-Atención Primaria. Hospital Universitario 12 de Octubre- Área 11 Atención Primaria, 2006.
10. Eccersley AJ, Wilson EM, Makris A, Novell JR. Referral guidelines for colorectal cancer-do they work? Ann R Coll Surg Engl 2003; 85: 107-10.
11. Flashman K, O'Leary DP, Senapati A, Thompson MR. The Department of Health's "two week standard" for bowel cancer: is it working? Gut 2004; 53: 387-91.
12. Chohan DPK, Goodwin K, Wilkinson S, Miller R. How has the "two-week wait" rule affected the presentation of colorectal cancer? Colorectal Dis 2005; 7: 450-3.
13. Smith RA, Oshin O, McCallum J et al. Outcomes in 2748 patients referred to a colorectal two-week rule clinic. Colorectal Dis 2007; 9: 340-3.
14. Debnath D, Dielehner N, Gunning KA. Guidelines, compliance, and effectiveness: a 12 months' audit in an acute district general healthcare trust on the two week rule suspected colorectal cancer. Postgrad Med J 2002; 78: 748-51.
15. Maruthachalam K, Stoker E, Chaudhri S, Noblett S, Horgan AF. Evolution of the two-week rule pathway-direct access colonoscopy vs outpatient appointments: one year's experience and patient satisfaction survey. Colorectal Dis 2005; 7: 480-5.
16. Goodman D, Irvin TT. Delay in the diagnosis and prognosis of carcinoma of the right colon. Br J Surg 1993; 80: 1327-9.
17. Roncoroni L, Pietra N, Violi V et al. Delay in the diagnosis and outcome of colorectal cancer: a prospective study. Eur J Surg Oncol 1999; 25: 173-8.
18. Charles RJ, Cooper GS, Wong RCK, Sivak MV, Chak A. Effectiveness of open-access endoscopy in routine primary-care practice. Gastrointest Endosc 2003; 57: 183-6.
19. Barwick TW, Scott SB, Ambrose NS. The two week referral for colorectal cancer: a retrospective analysis. Colorectal Dis 2004; 6: 85-91.
20. Hamilton W, Sharp D. Diagnosis of colorectal cancer in primary care: the evidence base for guidelines. Fam Pract 2004; 21: 99-106.
21. Walsh S, Bruce C, Bennington S, Ravi S. The fourteen-day rule and colorectal cancer. Ann R Coll surg Engl 2002; 84: 386-8.
22. Trickett JP, Donaldson DR, Bearn PE, Scott HJ, Hassall AC. A study on the routes of referral for patients with colorectal cancer and its affect on the time to surgery and pathological stage. Colorectal Dis 2004; 6: 428-31.
23. Chorost MI, Datta R, Santiago RC et al. Colon cancer screening: where have we come from and where do we go? J Surgical Oncol 2004; 85: 7-13.
24. Patwardhan MB, Samsa GP, McCrory DC et al. Cancer care quality measures: diagnosis and treatment of colorectal cancer. Evid Rep Technol Assess (Full Rep) 2006; 138: 1-116.
25. Castells A, Marzo M, Bellas B et al. Guía de práctica clínica. Prevención del cáncer colorrectal. Actualización 2009. Gastroenterol Hepatol 2009; 32: 717e1-58.
26. Iversen LH, Antonsen S, Laurberg S, Lautrup MD. Therapeutic delay reduces survival of rectal cancer but not of colonic cancer. Br J Surg 2009; 96: 1183-9.
27. Fernandez E, Porta M, Malats N, Belloc J, Gallén M. Symptom-todiagnosis interval and survival in cancers of the digestive tract. Dig Dis Sci 2002; 47: 2434-40.